INS and metabolic dysfunction-associated steatotic liver disease: Previous studies have shown that insulin resistance (IR) is a core pathophysiological mechanism shared by NAFLD and these obesity-related diseases (3, 26, 27); IR is a pathological state in which the body develops compensatory hyperinsulinemia due to various factors that lead to reduced insulin-promoted glucose uptake and utilization (28).